Mach 1 Financial Group, LLC Arcutis Biotherapeutics, Inc. Transaction History

Mach 1 Financial Group, LLC

  • $288 Million
  • Q2 2025

A detailed history of Mach 1 Financial Group, LLC transactions in Arcutis Biotherapeutics, Inc. stock. As of the latest transaction made, Mach 1 Financial Group, LLC holds 22,254 shares of ARQT stock, worth $554,569. This represents 0.11% of its overall portfolio holdings.

Number of Shares
22,254
Holding current value
$554,569
% of portfolio
0.11%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 11, 2025
BUY
$12.59 - $16.6 $280,177 - $369,416
22,254 New
22,254 $312,000

About Arcutis Biotherapeutics, Inc.

ARQT Quotes by TradingView
  • Ticker ARQT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,187,500
  • Market Cap $1.5B
  • Description
  • Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...
More about ARQT
Track This Portfolio

Track Mach 1 Financial Group, LLC Portfolio

Follow Mach 1 Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mach 1 Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mach 1 Financial Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email